Gene Therapies: A Wave is Coming Are Health Systems Ready?

The field of advanced cell and gene therapies is growing rapidly, with 23 new cell and gene therapies set to be approved in 2023 in the United States and European Union. These promising therapies mark a radical shift from traditional treatment modalities, addressing the underlying genetic causes of disease rather than merely treating symptoms. However, to harness their potential effectively, there is a need for innovation and adaptation that extends throughout the entire health sector. The impressive pace of progress in gene therapies therefore raises an important question for policy makers: are our health systems adequately prepared? Full article HERE